Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04936776 · ClinicalTrials.gov registry record
Pediatric Vaccinations
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 1,034
- Enrollment target
NCT04936776: Completed study, sponsored by NYU Langone Health.
NCT04936776 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 1,034 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04936776 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 1,034 participants
- Enrollment target
Study Summary
As the Covid-19 pandemic hit New York City in the spring of 2020, many families were home-bound due to the city-wide lockdown. As a result, families in New York City were unable to attend their child's healthcare appointments and many young children did not receive their regularly-scheduled vaccinations. Parts of the city-wide lockdown did eventually lift in the summer of 2020 as positive Covid-19 virus rates declined in NYC. However, regularly scheduled vaccination rates (non-Covid-related) remain low. Yet, it is critical that young children receive their mandatory vaccines in a timely manner to decrease the chance of contracting preventable illnesses. Thus, the investigators seek to increase vaccination rates among children ages 0-2 years in Sunset Park Brooklyn.
Interventions
- BEHAVIORAL Text messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,034 participants |
| Start Date | 2021-02-09 |
| Est. Completion | 2024-01-02 |
What the finished NCT04936776 record still lists
NCT04936776 is an observational study that tracks outcomes without assigning an intervention. Its 1,034 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Text messaging is the first listed.
NCT04936776 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04936776 about?
NCT04936776 is a clinical study titled "Pediatric Vaccinations". As the Covid-19 pandemic hit New York City in the spring of 2020, many families were home-bound due to the city-wide lockdown. As a result, families in New York City were unable to attend their child's healthcare appointments and many young children did not receive their regularly-scheduled vaccinat...
What is the current status of trial NCT04936776?
This trial is currently completed. The enrollment target is 1,034 participants. The study started on 2021-02-09. Estimated completion is 2024-01-02.
What interventions are being tested in trial NCT04936776?
The interventions under investigation include: Text messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT04936776?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05037682 · 1,035 participants · NA
Pain and Opioid Management in Older Adults
- NCT07282600 · 1,035 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NCT07084363 · 1,032 participants · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
- NCT07345767 · 1,038 participants · NA
Hypknowledge Nationwide Sleep Extension
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI